Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

An Open Non-randomized Multicenter Phase II Trial to Evaluate the Efficacy and Safety of Tarceva in Combination With Capecitabine in Patients With Advanced Pancreatic Cancer

NCT00873353 is registered in ClinicalTrials.gov with Grupo Gallego de Investigaciones Oncologicas as lead sponsor.

NCT NCT00873353
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00873353 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
An Open Non-randomized Multicenter Phase II Trial to Evaluate the Efficacy and Safety of Tarceva in Combination With Capecitabine in Patients With Advanced Pancreatic Cancer
Lead sponsor
Grupo Gallego de Investigaciones Oncologicas
Phase
Phase 2
Overall status
Completed
Start date
March 31, 2008
Completion date
August 31, 2010
Enrollment
32 (actual)
Sites
8

Conditions

As the registry lists them; a condition with its own page is linked.

metastatic adenocarcinoma of the pancreas